Equities

Delcath Systems Inc

Delcath Systems Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)9.05
  • Today's Change-0.33 / -3.52%
  • Shares traded308.48k
  • 1 Year change+105.68%
  • Beta0.8058
Data delayed at least 15 minutes, as of Sep 18 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Delcath Systems, Inc. is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. The Company's products, HEPZATO KIT (Hepzato (melphalan) for Injection/Hepatic Delivery System) and CHEMOSAT Hepatic Delivery System for Melphalan (CHEMOSAT) percutaneous hepatic perfusion (PHP) are designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects during a PHP procedure. HEPZATO KIT is a drug/device combination product designed to administer high-dose chemotherapy directly into the liver while limiting systemic exposure and associated side effects. In Europe, the hepatic delivery system is a stand-alone medical device having the same device components as HEPZATO KIT, but without the melphalan hydrochloride and is approved for sale under the trade name CHEMOSAT. In the United States, HEPZATO is regulated as a drug by the United States Food and Drug Administration (FDA).

  • Revenue in USD (TTM)11.88m
  • Net income in USD-56.33m
  • Incorporated1988
  • Employees76.00
  • Location
    Delcath Systems Inc566 Queensbury AvenueQUEENSBURY 12804United StatesUSA
  • Phone+1 (518) 743-8892
  • Fax+1 (212) 489-2102
  • Websitehttps://delcath.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Accuray Inc446.55m-15.55m188.56m1.02k--4.18--0.4223-0.1596-0.15964.530.45430.94232.145.36---3.28-1.37-5.61-2.3332.0536.42-3.48-1.550.9470.37570.7925---0.23551.29-67.51------
Neuropace Inc71.82m-29.90m203.21m171.00--20.52--2.83-1.09-1.092.610.33920.73051.746.49419,994.20-30.41---34.66--74.15---41.63--5.47-4.370.8565--43.72--30.00------
Nevro Corp426.10m-77.44m218.11m1.22k--0.7936--0.5119-2.12-2.1211.697.370.72661.115.93350,697.90-13.21-13.64-15.59-16.6868.0668.54-18.18-20.673.53-28.950.4433--4.631.88-3,172.74--0.9012--
LifeMD Inc178.28m-26.60m223.96m207.00------1.26-0.7004-0.70044.70-0.1013.596.8638.19861,255.40-44.31-153.05-333.96-526.9188.9283.66-12.34-45.440.8327-8.191.13--28.1578.9051.27--143.64--
Senseonics Holdings Inc24.04m-80.46m233.19m132.00--403.22--9.70-0.1323-0.13230.03950.07140.18152.585.99182,113.60-60.74-73.65-74.52-106.9712.04-40.41-334.69-649.862.89-10.930.5802--36.623.43-142.49---18.76--
Utah Medical Products, Inc.46.58m15.63m233.31m169.0015.491.8911.805.014.334.3312.9235.450.35761.9912.81275,609.5012.0012.6912.4313.1958.9961.5733.5630.5123.68--0.0037.05-3.933.640.98341.659.711.86
Alpha Teknova Inc34.94m-34.27m254.26m210.00--2.47--7.28-0.9295-0.92950.91671.930.28192.366.84166,381.00-27.65---32.36--22.38---98.08--3.28-29.500.144---11.43--22.52------
Inogen Inc326.65m-92.44m257.11m834.00--1.37--0.7871-3.97-3.9713.977.910.95626.857.49391,670.30-27.06-8.23-33.51-9.5342.5644.54-28.30-10.312.37--0.00---16.32-2.49-22.30--26.34--
Zynex Inc193.61m6.04m259.97m1.10k47.238.0624.571.340.17340.17345.731.021.412.566.85176,012.704.4014.584.9917.5280.3679.623.1210.443.225.740.642--16.5442.01-42.910.37412.19--
Delcath Systems Inc11.88m-56.33m262.64m76.00--62.50--22.11-2.55-2.550.5050.15010.43220.61986.17156,289.50-204.97-116.57-356.98-243.2177.0571.02-474.22-1,235.372.04-54.370.5172---24.05-9.53-30.60---5.26--
Atlantic International Corp205.26m-62.29m306.99m7.00--12.07--1.50-8.72-8.7214.590.52222.91--7.0329,322,780.00-88.44-71.97-174.30-106.0910.7061.01-30.35-1,471.82---1.330.7735---100.00---37.43------
AngioDynamics, Inc.303.91m-184.35m307.71m748.00--1.50--1.01-4.57-4.577.565.080.71482.576.30406,302.10-43.36-16.38-54.60-18.7050.9052.95-60.66-30.491.46--0.00---10.282.35-251.53--13.09--
Pulmonx Corp76.58m-57.86m320.27m279.00--3.17--4.18-1.50-1.501.992.580.41881.217.65274,491.00-31.64-26.27-35.08-28.9774.1971.95-75.56-93.767.92--0.2688--27.9827.98-3.26--20.62--
Treace Medical Concepts Inc198.53m-63.68m324.01m516.00--2.89--1.63-1.03-1.033.211.800.83471.147.52384,753.90-26.77---31.74--80.67---32.08--2.93--0.3216--31.92---15.68------
OraSure Technologies, Inc.273.54m27.03m327.35m638.0012.160.76878.211.200.36110.36113.685.710.59472.726.02428,738.306.000.72386.530.821244.6246.9410.091.1310.84--0.00180.004.6417.41413.1782.2010.18--
Clearpoint Neuro Inc28.07m-17.98m328.94m107.00--10.23--11.72-0.7062-0.70621.101.160.56021.318.95262,327.10-35.89-34.75-46.51-39.6759.8564.75-64.06-76.912.31--0.237--16.5626.64-34.40--75.30--
Data as of Sep 18 2024. Currency figures normalised to Delcath Systems Inc's reporting currency: US Dollar USD

Institutional shareholders

33.94%Per cent of shares held by top holders
HolderShares% Held
Rosalind Advisors, Inc.as of 30 Jun 20242.65m12.02%
AIGH Capital Management LLCas of 30 Jun 20242.40m10.89%
The Vanguard Group, Inc.as of 30 Jun 2024985.01k4.47%
Essex Investment Management Co. LLCas of 30 Jun 2024335.90k1.52%
Geode Capital Management LLCas of 30 Jun 2024244.60k1.11%
CIBC World Markets, Inc.as of 30 Jun 2024229.07k1.04%
Adar1 Capital Management LLCas of 30 Jun 2024198.35k0.90%
Avenue Capital Management II LPas of 30 Jun 2024161.83k0.73%
Shellback Capital LPas of 30 Jun 2024161.69k0.73%
Legato Capital Management LLCas of 30 Jun 2024115.46k0.52%
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.